Recursion Pharmaceuticals
RXRX
RXRX
330 hedge funds and large institutions have $1.57B invested in Recursion Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 110 increasing their positions, 89 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
1% less funds holding
Funds holding: 333 → 330 (-3)
2% less capital invested
Capital invested by funds: $1.61B → $1.57B (-$39.8M)
3% less first-time investments, than exits
New positions opened: 58 | Existing positions closed: 60
Holders
330
Holding in Top 10
9
Calls
$55.7M
Puts
$41M
Top Buyers
| 1 | +$24.6M | |
| 2 | +$19.1M | |
| 3 | +$6.74M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.85M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$4.29M |
Top Sellers
| 1 | -$9.64M | |
| 2 | -$9.24M | |
| 3 | -$9.07M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$8.51M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$8.19M |
